Showing results (1121-1130 of 1,274) with videos related to
Sort By:
Pageof 128
The Lancet. Neurology|June 15, 2013
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, David K B Li, Hans-Peter Hartung, et al.Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2012
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosisIris-Katharina Penner, Brigitte Stemper, Pasquale Calabrese, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinumJ J Kavanagh, A P Kudelka, C G de Leon, et al.Biorxiv : the Preprint Server for Biology|May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob H Hullsiek, Kate J Dixon, et al.Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.Journal of Translational Medicine|April 11, 2006
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinSachin M Apte, Saroj Vadhan-Raj, Lorenzo Cohen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaR S Freedman, A P Kudelka, J J Kavanagh, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.American Journal of Epidemiology|March 20, 2015
Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for potassium and sodium intakeLaurence S Freedman, John M Commins, James E Moler, et al.Pageof 128